GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $41,000 | +10.8% | 1,271 | +20.5% | 0.01% | +20.0% |
| Q1 2022 | $37,000 | +19.4% | 1,055 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $31,000 | +19.2% | 1,055 | 0.0% | 0.00% | +33.3% |
| Q3 2021 | $26,000 | -25.7% | 1,055 | +5.2% | 0.00% | -40.0% |
| Q2 2021 | $35,000 | -86.7% | 1,003 | -84.5% | 0.01% | -86.8% |
| Q1 2021 | $263,000 | +2.3% | 6,462 | +8.9% | 0.04% | -7.3% |
| Q4 2020 | $257,000 | – | 5,935 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |